Latest Commercial Contracts News

Environmental Clean Technologies Limited is set to acquire exclusive rights to Rice University’s breakthrough Flash Joule Heating technology for PFAS soil remediation, backed by a $3 million capital raise and leadership changes.

Hydrocarbon Dynamics Limited has reactivated its North Sea trial and completed a fully underwritten rights issue raising $718,741, while advancing multiple international projects and exploring new energy ventures.

Zeotech Limited has locked in a $204 million binding offtake agreement for its kaolin products and successfully demonstrated its AusPozz™ low-carbon metakaolin in a large-scale concrete pour, signaling strong momentum in its commercialisation efforts.

Zoono Group Limited has responded to an ASX price query following a recent surge in its share price and trading volume, confirming no undisclosed information exists and attributing market activity to ongoing shelf-life extension trials across multiple continents.

Adherium Limited’s iCARE study reports unprecedented medication adherence improvements and sustained patient engagement in COPD and asthma care, highlighting significant clinical and economic benefits.

1414 Degrees has completed all technical milestones with Woodside, retaining full ownership of its SiBox technology and advancing commercialisation efforts in industrial decarbonisation and hydrogen.

Metal Powder Works has achieved a key validation milestone for its commercially pure titanium powder, confirming performance on par with industry benchmarks for cold spray applications. This breakthrough positions MPW to expand into the lucrative aerospace and advanced manufacturing markets.

4DMedical Limited has secured FDA clearance for CT – VQ™, the first non-contrast CT-based ventilation-perfusion imaging technology, promising to transform lung diagnostics by replacing traditional nuclear scans.

Novatti Group reports a record $51.8 million revenue for FY25 alongside a 65% improvement in underlying EBITDA, signaling a successful turnaround and a strategic pivot back to growth.

Genetic Signatures reported a 63% revenue increase to $15.9 million in FY25, alongside a 28% reduction in underlying losses and a strategic shift in its automated diagnostics platform development.

Artrya Limited reported a 17.2% increase in net loss to $16.4 million for FY25, while achieving FDA clearance and launching its AI-driven Salix platform in the U.S. market. The company also secured key commercial partnerships in Australia and raised $20 million in equity funding.

Aquirian’s subsidiary TBS Mining Solutions has secured a $4.2 million binding term sheet with Papyrus Australia to manufacture biodegradable Collar Keeper® products, marking a significant step towards greener mining operations.